title: [Angio-immunoblastic lymphadenopathy].
abstract: Angioimmunoblastic lymphadenopathy is a rare lymphoproliferative disease with a poor prognosis. We saw a 24-year-old female patient with a fulminant evolution of an angioimmunoblastic lymphadenopathy, possibly a recurrence after a 10 years remission.
authors.affiliation: Afd. Inwendige Ziekten, Algemeen Ziekenhuis Middelheim, Antwerpen, België.
authors.forename: N J
authors.initials: NJ
authors.lastname: Struyf
authors.forename: J A
authors.initials: JA
authors.lastname: Verhelst
authors.forename: C G
authors.initials: CG
authors.lastname: Convens
authors.forename: W J
authors.initials: WJ
authors.lastname: Beelaerts
authors.forename: R J
authors.initials: RJ
authors.lastname: Mathijs
authors.forename: C
authors.initials: C
authors.lastname: Mahler
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Angio-immunoblastische lymfadenopathie.